4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001209191-20-008370
Options or other derivatives
- Chief Medical Officer acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Arbet-Engels Christophe Chief Medical Officer | 2020-02-10 | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | D | ||
Loading xslF345X03/doc4.xml…